Skip to main content
TipRanks
Go Ultimate75% OFF

SELLAS Life Sciences Group (RXK3) Income Statement

2 Followers

SELLAS Life Sciences Group Income Statement

Last quarter (Q3 2026), SELLAS Life Sciences Group's total revenue was $0.00. In Q3, SELLAS Life Sciences Group's net income was $-10.09M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 1.00M$ 7.60M
$ 0.00$ 0.00$ 0.00$ 900.00K$ 7.40M
$ 28.27M$ 31.51M$ 37.87M$ 42.85M$ 32.69M
Depreciation and Amortization$ 0.00$ 31.51M$ 37.87M$ 457.00K$ 1.27M
$ -26.86M$ 632.00K$ 529.00K$ -31.49M$ -18.32M
$ -28.27M$ -31.51M$ -37.87M$ -41.95M$ -25.29M
$ 1.41M$ 632.00K$ 529.00K$ 649.00K$ 4.36M
$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.94M
$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.70M
Per Share Metrics
Basic EPS$ -0.25$ -0.50$ -1.34$ -2.13$ -1.34
Diluted EPS$ -0.25$ -0.50$ -1.34$ -2.13$ -1.34
Weighted Average Shares Outstanding109.05M61.20M27.78M19.39M15.48M
Weighted Average Shares Outstanding (Diluted)109.05M61.20M27.78M19.40M15.48M

Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

-50M-25M025M-4500 %-3000 %-1500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin